Table 5. Risk of death by trajectory.

Model adjusted for age, race, gender, for age, race, gender, diabetes mellitus, hypertension, cardiovascular disease, hyperlipidemia, peripheral artery disease, cerebrovascular disease, chronic lung disease, hepatitis C, HIV, dementia, and eGFR at time of cohort entry (T0). Reference group is patients with stable kidney function before cohort entry (T0).

	1-year HR (CI)	3-year HR (CI)	5-year HR (CI)	9-year HR (CI)
A	8.66 (7.34–10.23)	6.08 (5.38–6.87)	5.45 (4.91–6.05)	4.49 (4.10–4.91)
B	1.37 (1.18–1.60)	1.41 (1.29–1.54)	1.47 (1.37–1.58)	1.46 (1.39–1.54)
C	1.45 (1.32–1.60)	1.35 (1.27–1.43)	1.25 (1.19–1.31)	1.14 (1.10–1.19)
D	1.55 (1.43–1.68)	1.30 (1.23–1.36)	1.21 (1.16–1.26)	1.12 (1.09–1.15)
E	1.73 (1.58–1.90)	1.28 (1.21–1.37)	1.23 (1.17–1.29)	1.20 (1.16–1.24)
F	2.66 (2.25–3.14)	1.78 (1.58–2.01)	1.65 (1.50–1.81)	1.61 (1.49–1.73)
G	2.54 (2.22–2.90)	2.04 (1.87–2.22)	2.06 (1.93–2.21)	2.10 (1.99–2.22)